Medical research is essential to advancing pain care. On Sept. 25, U.S. Pain members were treated to a webinar covering the ins and outs of medical research studies. The event, “Patient empowerment in clinical trials,” was presented by Lindsay Wahlstrom-Edwards, Director of Partnerships at Antidote, a digital health company that helps connect patients with clinical trial opportunities.
During her talk, Wahlstrom-Edwards explained the different types of clinical research and key terms, like “protocol” and “principal investigator.” She also talked about the importance of engagement. According to Wahlstrom-Edwards, approximately 80 percent of medical research is delayed or cancelled due to difficult enrolling participants.
The Ouchie app is successfully used by thousands of people to track and manage their chronic pain. It’s also a powerful platform for connecting with and getting support from fellow patients.
The team behind Ouchie recently created a new series that features the stories and perspectives of people living with chronic pain, including members of U.S. Pain. Download the app to learn more about members like Jason Schutz of the blog, “Ain’t No Shame in Chronic Pain,” who wrote a piece about the value of support groups. You can also find helpful tips and resources from clinical experts.
Patients with back pain in Delaware will have access to interdisciplinary pain care, following Gov. John Carney’s signing of Senate Bill 225.
The act develops a pilot program within the state employee health care plan that allows the use of massage therapy, acupuncture, and yoga to treat back pain. It also prohibits health plans from placing annual or lifetime limits on chiropractic and physical therapy visits.
Take Control of Your Pain Days are a chance to learn about the latest advances in pain management, research, and other helpful resources from leading experts — while connecting with fellow pain warriors. U.S. Pain is co-hosting two upcoming Take Control of Your Pain Days: on Oct. 20 in Chicago, IL, and on Nov. 10 in Boston, MA.
The events are free and open to all. Lunch will be provided. For more details or to register, visit https://uspainfoundation.org/tcoyp/.
U.S. Pain Foundation seeks to educate its members about all possible forms of treatment. Buprenorphine is one pain medication that has recently made headlines as a safer alternative to traditional opioid medications. Because it is a partial opioid agonist, it alleviates pain with less risk of euphoria and physical dependence as well as a smaller chance of respiratory depression.
U.S. Pain recently collaborated with The Herald Group to conduct an educational survey on members’ experiences with buprenorphine. More than 800 individuals responded. Here are some of the key findings from that survey: